Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Trastornos del Movimiento
FILTRAR POR:
Por tema
5589 ARTÍCULOS , VIENDO DEL 4996 AL 5010
Cortical thickness as predictor of response to exercise in people with Parkinson's disease
Silva-Batista C, Ragothaman A, Mancini M, Carlson-Kuhta P, Harker G, Jung SH, Nutt JG, Fair DA, Horak FB, Miranda-Domínguez O.
Hum Brain Mapp. 2021 Jan;42(1):139-153. doi: 10.1002/hbm.25211. Epub 2020 Oct 9.
Li L, Acioglu C, Heary RF, Elkabes S.
Brain Behav Immun. 2021 Jan;91:740-755. doi: 10.1016/j.bbi.2020.10.007. Epub 2020 Oct 8.
Catechol-O-Methyltransferase Genotype, Frailty, and Gait Speed in a Biracial Cohort of Older Adults
Mance S, Rosso A, Bis J, Studenski S, Bohnen N, Rosano C.
J Am Geriatr Soc. 2021 Feb;69(2):357-364. doi: 10.1111/jgs.16842. Epub 2020 Oct 12.
Probiotics for Constipation in Parkinson Disease: A Randomized Placebo-Controlled Study
Tan AH, Lim SY, Chong KK, A Manap MAA, Hor JW, Lim JL, Low SC, Chong CW, Mahadeva S, Lang AE.
Neurology. 2021 Feb 2;96(5):e772-e782. doi: 10.1212/WNL.0000000000010998. Epub 2020 Oct 12.
Dodel R, Tinelli M, Deuschl G, Petersen G, Oertel W, Ahmerkamp-Böhme J.
Eur J Neurol. 2021 Feb;28(2):707-716. doi: 10.1111/ene.14584. Epub 2020 Nov 8.
Emerging role of S100B protein implication in Parkinson's disease pathogenesis
Angelopoulou E, Paudel YN, Piperi C.
Cell Mol Life Sci. 2021 Feb;78(4):1445-1453. doi: 10.1007/s00018-020-03673-x. Epub 2020 Oct 14.
Neuroinflammatory responses in Parkinson's disease: relevance of Ibuprofen in therapeutics
Singh A, Tripathi P, Singh S.
Inflammopharmacology. 2021 Feb;29(1):5-14. doi: 10.1007/s10787-020-00764-w. Epub 2020 Oct 14.
Inflammatory bowel disease and Parkinson's disease: common pathophysiological links
Lee HS, Lobbestael E, Vermeire S, Sabino J, Cleynen I.
Gut. 2021 Feb;70(2):408-417. doi: 10.1136/gutjnl-2020-322429. Epub 2020 Oct 16.
Selective autophagy as a therapeutic target for neurological diseases
Xu W, Ocak U, Gao L, Tu S, Lenahan CJ, Zhang J, Shao A.
Cell Mol Life Sci. 2021 Feb;78(4):1369-1392. doi: 10.1007/s00018-020-03667-9. Epub 2020 Oct 16.
The glutathione system in Parkinson's disease and its progression
Bjørklund G, Peana M, Maes M, Dadar M, Severin B.
Neurosci Biobehav Rev. 2021 Jan;120:470-478. doi: 10.1016/j.neubiorev.2020.10.004. Epub 2020 Oct 14.
Neurological disorders vis-à-vis climate change
Zammit C, Torzhenskaya N, Ozarkar PD, Calleja Agius J.
Early Hum Dev. 2021 Apr;155:105217. doi: 10.1016/j.earlhumdev.2020.105217. Epub 2020 Oct 1.
Davis G, Levine Z.
Stereotact Funct Neurosurg. 2021;99(1):38-39. doi: 10.1159/000510122. Epub 2020 Oct 16.
Adapting to post-COVID19 research in Parkinson's disease: Lessons from a multinational experience
Tan EK, Albanese A, Chaudhuri K, Lim SY, Oey NE, Shan Chan CH, Wu YC, Jeon B, Truong D, Poewe W, Pal PK, Tan L, Opal P, Colosimo C, Jinnah HA, Cardoso F.
Parkinsonism Relat Disord. 2021 Jan;82:146-149. doi: 10.1016/j.parkreldis.2020.10.009. Epub 2020 Oct 7.
Randomized, Controlled Study of Opicapone in Japanese Parkinson's Patients with Motor Fluctuations
Takeda A, Takahashi R, Tsuboi Y, Nomoto M, Maeda T, Nishimura A, Yoshida K, Hattori N.
Mov Disord. 2021 Feb;36(2):415-423. doi: 10.1002/mds.28322. Epub 2020 Oct 19.
Neuroprotective Effects of Molecular Hydrogen: A Critical Review
Chen W, Zhang HT, Qin SC.
Neurosci Bull. 2021 Mar;37(3):389-404. doi: 10.1007/s12264-020-00597-1. Epub 2020 Oct 20.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.